Planning for potential disruption in 2023 will be crucial for pharmaceutical companies that wish to mitigate supply chain woes further down the line. The situation regarding COVID-19 in China is already being hailed as a potential source of supply chain disruption, with some organisations…
Source: www.pmlive.com – Read more
Supply chain challenges in 2023
Must Read
Cybersecurity funding to surge this financial year: Adapt
Following a year-on-year survey of 181 Australian Chief Information Security Officers (CISOs)...
